Item 2.02 - Results of Operations and Financial Condition

On January 13, 2020, Apyx Medical Corporation issued a press release reporting on its preliminary revenue results for the quarter and year ended December 31, 2019.


A copy of the press release is furnished as Exhibit 99.1 to this Current Report
on Form 8-K and is incorporated herein by reference. The information in this
report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and
shall not be deemed to be "filed" for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section. This report will not be deemed an admission as to
the materiality of any information herein (including Exhibit 99.1).
Item 9.01 - Financial Statements and Exhibits
(d)
Exhibit No.   Description

99.1            Press release dated January 13, 2020

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 13, 2020 By: /s/ TARA SEMB

Tara Semb
                           Chief Financial Officer, Treasurer, and Secretary

© Edgar Online, source Glimpses